
Vxtab 37.5mg Tablet XR
Marketer
Sycap Pharma
Salt Composition
Venlafaxine (37.5mg)
Overview Vxtab 37.5mg Tablet XR
Anixil XR 37.5mg tablets treat anxiety and depression by modifying brain chemistry responsible for symptoms like restlessness, poor concentration, tiredness, excessive sweating, rapid heartbeat, irritability, and racing thoughts. Take Anixil XR 37.5mg with food, at the same time daily for consistent blood levels. If a dose is missed, take it immediately upon remembering; avoid skipped doses and complete the prescribed course, even with symptom improvement. Abrupt discontinuation may worsen symptoms; gradual cessation is essential. Potential side effects include nausea, vomiting, sleep disturbances, reduced appetite, increased anxiety, constipation, hyperhidrosis, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks demanding alertness until the medication's effects are known. Most side effects are transient. Persistent or bothersome side effects require medical attention. Before starting Anixil XR 37.5mg, disclose any kidney, heart, or liver issues, or history of seizures. Report any unusual mood shifts, worsening depression, or suicidal ideation to your physician.
Uses of Vxtab 37.5mg Tablet XR
Mood disorders encompassing sadness and worry
Major Benefits of Vxtab 37.5mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The extended-release Vxtab 37.5mg tablet should be taken with a meal.
Common Side effects of Vxtab 37.5mg Tablet XR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Vxtab 37.5mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 37.5mg extended-release Vxtab tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with a meal.
How Vxtab 37.5mg Tablet XR works:
Extended-release Vxtab 37.5mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Vxtab 37.5mg Extended-Release Tablets; doing so is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Vxtab 37.5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vxtab 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Infants should be observed for drowsiness and appropriate weight increase.
DrivingUNSAFE
Driving ability may be impaired by Vxtab 37.5mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving capabilities.
KidneyCAUTION
Extended-release Vxtab 37.5mg tablets require careful administration for individuals with impaired renal function. Dosage modification of Vxtab 37.5mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Vxtab 37.5mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Vxtab 37.5mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Vxtab 37.5mg Tablet XR :
Should you forget a Vxtab 37.5mg Extended-Release Tablet, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Vxtab 37.5mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Anise-derived compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
| Behavior Class | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
